Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
---|
12/07/2006 | WO2006128674A2 Combinations of indacaterol derivatives and other agents for the treatment of airway diseases |
12/07/2006 | WO2006128660A1 Combination of hmg-coa reductase inhibitors amd mtor inhibitors |
12/07/2006 | WO2006086445A8 Combination therapy |
12/07/2006 | WO2006052608A3 Treatment of obesity and related disorders |
12/07/2006 | WO2006015137A3 A method for managing cholesterol with a serum-free and mitogen free cytokine mixture |
12/07/2006 | WO2005110464A3 Irx5 inhibition as treatment for hyperproliferative disorders |
12/07/2006 | WO2005079848A9 Agonists and antagonists of p28 ebi3 and wsx/tccr for treating immune disorders |
12/07/2006 | WO2004071435A3 Enhanced Bioavailability Using Laser Resonant Homogenization |
12/07/2006 | WO2004024882A3 FLJ20647s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
12/07/2006 | US20060276548 Inhibitors of endo-exonuclease activity for treating cancer |
12/07/2006 | US20060276531 Agent for the treatment of bladder irritative symptoms accompanied by benign prostatic hyperplasia |
12/07/2006 | US20060276527 Combination therapies for the treatment of cancer |
12/07/2006 | US20060276517 Non-systemic control of parasites |
12/07/2006 | US20060276491 Therapeutic compounds |
12/07/2006 | US20060276473 Use and administration of bacterial efflux pump inhibitors |
12/07/2006 | US20060276439 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
12/07/2006 | US20060276419 Combined use of ribavirin and interferon beta in demyelinating diseases |
12/07/2006 | US20060276417 Procyanidins as antineoplastic agents; topolisomerase, cylooxygenase, and/or lipoxygenase inhibitors; nitric oxide synthase modulators; hypotensive agents |
12/07/2006 | US20060276414 Use of compositions comprising an estrogenic component for the treatment and prevention of musculoskeletal pain |
12/07/2006 | US20060276398 Combined use of factor VII polypeptides and factor VIII polypeptides |
12/07/2006 | US20060276392 Treatments employing neuronal exocytosis-inhibiting peptides |
12/07/2006 | US20060276381 Remedy for diabetes |
12/07/2006 | US20060276339 Methods and compositions for increasing the efficacy of biologically-active ingredients |
12/07/2006 | US20060275898 Compositions and Methods for Making Embryonic Stem Cells |
12/07/2006 | US20060275770 Heart failure gene determination and therapeutic screening |
12/07/2006 | US20060275758 Use of pp2a phosphatase modulators in the treatment of mental disorders |
12/07/2006 | US20060275755 Novel nucleic acids and polypeptides related to a guanine exchange factor of rho gtpase |
12/07/2006 | US20060275507 Composition for preventive treatment of cold sores |
12/07/2006 | US20060275503 Such as strontium ranelate in combination with a drug that reduces the incidence of bone fracture and/or increases bone density and/or improves healing of fractured bone, such as a SERM, vitamin D2/D3, or parathyroid hormone; tablets |
12/07/2006 | US20060275357 Organic compounds |
12/07/2006 | US20060275348 Method for preventing or treating thrombosis |
12/07/2006 | US20060275326 Administering a botulinum toxin |
12/07/2006 | US20060275325 Method for treating allodynia by peripheral administration of a neurotoxin |
12/07/2006 | US20060275319 Saccharomyces cerevisiae yeast strain with functional expression of a GLUT transporter |
12/07/2006 | US20060275308 Combination of gallium compounds with nonchemotherapeutic anticancer agents in the treatment of neoplasia |
12/07/2006 | US20060275305 HERCEPTIN adjuvant therapy |
12/07/2006 | US20060275298 Antagonist of Th-1 immuneresponse inducing cytokine for the treatment of autoimmune diseases |
12/07/2006 | US20060275284 Combination therapy for treatment of autoimmune diseases using b-cell depleting/immunoregulatory antibody combination |
12/07/2006 | US20060275277 Use of coagulation proteins to lyse clots |
12/07/2006 | US20060275273 Intervertebral Disc Repair, Methods and Devices Therefor |
12/07/2006 | DE60118395T2 Pharmazeutische zusammensetzungen mit verzögerter freisetzung für die parenterale applikation von hydrophilen wirkstoffen Pharmaceutical compositions of active ingredients with controlled release for the parenteral administration of hydrophilic |
12/07/2006 | CA2610692A1 Ep2 agonists which may have an ep3 agonistic effect for regeneration and/or protection of nerves |
12/07/2006 | CA2609784A1 Novel method of treating hyperlipidemia |
12/07/2006 | CA2609783A1 Combination of a cannabinoid-1- receptor-antagonist and a microsomal triglyceride transfer protein inhibitor for treating obesity or mainataining weight loss |
12/07/2006 | CA2609617A1 Feline probiotic lactobacilli |
12/07/2006 | CA2609522A1 Indacterol derivatives and phosphodiesterase inhibitors for the treatment of airway diseases |
12/07/2006 | CA2609429A1 Medicament containing a betamimetic in conjunction with an anticholinergic and a pde iv inhibitor |
12/07/2006 | CA2609352A1 Delivery systems |
12/07/2006 | CA2608879A1 Combination of hmg-coa reductase inhibitors amd mtor inhibitors |
12/07/2006 | CA2608704A1 Combinations of indacaterol derivatives and other agents for the treatment of airway diseases |
12/06/2006 | EP1728519A2 Polar supporting and broad-band resonant preparation |
12/06/2006 | EP1728513A2 Stable desloratadine compositions |
12/06/2006 | EP1728510A2 Treating cancer by increasing intracellular malonyl coA levels |
12/06/2006 | EP1728508A1 Medicine for prevention or treatment of frequent urination or urinary incontinence |
12/06/2006 | EP1728504A1 Emulsion stabilizer |
12/06/2006 | EP1727833A1 Recombinant polypeptides of the members of the tnf ligand family and use thereof |
12/06/2006 | EP1727535A1 Combinations comprising alpha-2-delta ligands |
12/06/2006 | EP1727531A1 Combined pharmaceutical composition for the inhibition of the decline of cognitive functions |
12/06/2006 | EP1631146A4 Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments |
12/06/2006 | EP1430304B1 Method for diagnosing chronic inflammatory bowel diseases |
12/06/2006 | EP1397135B1 Combination of a pde4 inhibitor and tiotropium or derivative thereof for treating obstructive airways |
12/06/2006 | EP1218381B1 AMINO SUBSTITUTED PYRAZOLO¬1,5-a|-1,5-PYRIMIDINES AND PYRAZOLO¬1,5-a|-1,3,5-TRIAZINES |
12/06/2006 | EP1165078B1 Methods of inducing cancer cell death and tumor regression |
12/06/2006 | EP1119360B1 Compositions for increasing intestinal absorption of fats |
12/06/2006 | EP1044006B1 Use of an antimicrobial agent such as taurolidine or taurultam in the manufacture of a medicament to treat a nosocomial microbial infection |
12/06/2006 | EP0969865B1 Mhc class ii antigen-presenting systems and methods for activating cd4?+ t cells |
12/06/2006 | EP0948334B1 Method of treating prostatic diseases using active vitamin d analogues |
12/06/2006 | EP0740701B1 Mammalian monocyte chemoattractant protein receptors |
12/06/2006 | CN1874991A Compound capable of binding S1P receptor and pharmaceutical use thereof |
12/06/2006 | CN1874791A Pharmaceutical composition, containing a beta-3-adrenoceptor agonist and an alpha antagonist and/or a 5-alpha-reductase inhibitor |
12/06/2006 | CN1874790A Therapeutic agent for mesothelioma |
12/06/2006 | CN1874785A Immunotherapic agent which is used for the combined treatment of tuberculosis together with other pharmaceuticals |
12/06/2006 | CN1874781A Compositions of botanical extracts for cancer therapy |
12/06/2006 | CN1874780A Method of inhibiting the expression of a multi-drug resistance genes and inhibiting the production of proteins resulting from the expression of such genes thereby enhancing the effectiveness of chemot |
12/06/2006 | CN1874779A Combinations comprising AMPA receptor antagonists for the treatment of schizophrenia |
12/06/2006 | CN1874774A Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester |
12/06/2006 | CN1874753A Controlled release analgesic suspensions |
12/06/2006 | CN1873003A 真菌细胞壁合成基因 Fungal cell wall synthesis genes |
12/06/2006 | CN1873002A 真菌细胞壁合成基因 Fungal cell wall synthesis genes |
12/06/2006 | CN1872347A Cell preparation capable of excreting chalone of endothelium, and application for preparing medicine for treating tumour |
12/06/2006 | CN1872340A Genic bacterin for preventing and / or treating cancer |
12/06/2006 | CN1872339A Soakage of medication for treating arthritis |
12/06/2006 | CN1872026A New medicinal preparation for vagina |
12/06/2006 | CN1288158C Therapeutic or preventive agent for nausea/vomiting |
12/06/2006 | CN1288148C 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
12/06/2006 | CN1287860C Combination of medication containing reductase inhibitor HMG CoA and Melatonin |
12/06/2006 | CN1287859C Magnetic targeted carrier composed of iron and porous materials for targeted delivery of biologically active agents |
12/06/2006 | CN1287853C Treatment of follicular lymphomas using inhibitors of the lymphotoxin (LT) pathway |
12/06/2006 | CN1287852C Drugs containing as active ingredient midkine or inhibitors thereof |
12/06/2006 | CN1287850C Vaccines, immunotherapeutics and methods for using same |
12/06/2006 | CN1287804C Suspension of Fe#-[3]O#-[4] microparticle and iodized oil for treating liver and kidney tumor by embolizing and its preparation process |
12/06/2006 | CN1287803C Partial mouth composition for promoting whole body health and its application |
12/06/2006 | CN1287789C Application of 15-fat oxidase inhibitor in preparing medicine for treating and preventing bone loss |
12/06/2006 | CN1287781C Use of KCNQ potassium excitant in preparation of medicine with the functions of inducing or maintaining bladder performances |
12/06/2006 | CN1287778C Use of N,N-diethyl-2-[-4-(phenylmethyl)-phenoxy]ethanamine monohydrochloride (dppe) in cancer therapy |
12/06/2006 | CN1287768C Stabilized oral suspension formulation |
12/05/2006 | US7145032 Treating neuronal injury and for life-extension |
12/05/2006 | US7144997 Vertebrate embryonic patterning-inducing proteins, compositions and uses related therto |
12/05/2006 | US7144913 Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists |
12/05/2006 | US7144900 Pharmaceutical composition |